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in this population over 5 years as a result of this intervention. Health care payors should
consider development of financial incentives to encourage collaborative quality improve-
ment programs.
1077-74 Marked Underutilization and Geographic Variation in 
Secondary Prevention Pharmacologic Therapy in 
Patients With Chronic Angina Undergoing Treatment 
With Enhanced External Counterpulsation
Andrew D. Michaels, Sheryl Kelsey, Ozlem Soran, Elizabeth E. Kennard, University of 
California, San Francisco, San Francisco, CA, University of Pittsburgh, Pittsburgh, PA
Introduction: Despite the importance of antiplatelet agents, beta-blockers, angiotensin-
converting enzyme inhibitors (ACEIs), and hypolipidemic agents in patients with chronic
coronary artery disease (CAD), several studies have suggested that these agents are
substantially underutilized. Hypothesis: We sought to describe the contemporary use of
these pharmacologic agents among patients with chronic angina who were referred for
treatment with enhanced external counterpulsation (EECP). EECP is reserved for
patients with angina despite maximal medical therapy and revascularization. We sought
to test the hypothesis that there is geographic variation in the use of these therapies in
CAD patients. Methods: The International EECP Patient Registry (IEPR) enrolls consec-
utive patients undergoing EECP for chronic angina. We analyzed data on 4388 US
patients who underwent EECP for angina and were enrolled in the IEPR beginning in
January 1998. US Census definitions were used to categorize patients into 4 geographic
regions: Northeast (NE), West, South, and Midwest (MW). Results: This study included
1350 NE patients, 463 West patients, 1232 South patients, and 1343 MW patients.
Demographic and clinical characteristics, including age, sex, Caucasian race, prior MI,
diabetes, and hyperlipidemia, were similar among the 4 regions. Patients in the South
had the lowest incidence of prior coronary revascularization, multivessel disease, and
quality of life, while having the highest incidence of current smoking (9.5% in South vs
7.6% non-South). Patients in the MW had the highest mean angina class. South patients
had the lowest use of cardiac medication, including beta-blockers (55% in South vs 70%
non-South; p<.001) and aspirin (65% vs 74%; p<.001). There was no geographic varia-
tion in the use of calcium blockers (45% overall), ACEIs (38%), or lipid-lowering agents
(70%). Conclusions: There is substantial underutilization of antiplatelet agents, beta-
blockers, ACEIs, and hypolipidemic agents in US patients with chronic stable angina.
Variation across the country is striking, but all areas can improve the care of such
patients by increasing the appropriate use of these agents.
1077-75 Coronary Artery Bypass Grafting: Are We Getting With 
the Program?
Morley A. Herbert, Syma L. Prince, Mitchell J. Magee, Eric Eichhorn, Cardiopulmonary 
Research Science and Technology Institute, Dallas, TX, Medical City Dallas Hospital, 
Dallas, TX
Background: To minimize future cardiac events, American Heart Association guidelines
(1995, 2001) for treatment of patients with coronary artery disease recommended that
patients should be discharged on appropriate medications- beta-blocker, ACE inhibitor,
aspirin or other anti-platelet medication and cholesterol lowering medication when appro-
priate. This study examines discharge medicines prescribed patients after coronary
artery bypass grafting (CABG).
Methods: Data was exported from our STS certified database on 6914 patients undergo-
ing CABG between Jan 2000 and July 2003, and analyzed for the use of beta-blockers,
ACE inhibitors, aspirin (or other anti-platelet drug) and cholesterol lowering agent at dis-
charge.
Results: At discharge 10.3% of patients were prescribed all four classes of drugs, a fur-
ther 34.2% received 3 of the drugs, and 4.3% had no drugs prescribed (Table 1)
Of patients receiving only 1 drug at discharge, 86% were given aspirin or other antiplate-
let medication. When prescribed 2 drugs, 96.0% received aspirin, while beta-blockers
were prescribed to 56.9% and cholesterol lowering agents to 32.3% of the patients. In 3
drug regimens, aspirin was used in 99.1%, cholesterol lowering agents in 87.1% and
beta-blockers in 84.4% of the patients. Only 29.4% received a prescription for an ACE-
inhibitor.
Conclusions: Despite published medication guidelines, only 44.5% of patients being dis-
charged after CABG received prescriptions following the recommended drug regimen.
1077-76 Holiday Heart: Decreased Use of Evidence-Based 
Therapies in Patients With Acute Myocardial Infarction 
Admitted During Holiday Weeks
Trip J. Meine, Manesh R. Patel, Venita DePuy, Lesley Curtis, Sunil V. Rao, Kevin J. 
Schulman, James G. Jollis, Duke University Medical Center, Durham, NC, Duke Clinical 
Research Institute, Durham, NC
Background: Previous studies have found an increased mortality from myocardial infarc-
tion in December. We investigated the relationship between the use of evidence-based
therapies and admission during holiday weeks.
Methods: 134,609 patients in an observational Medicare database admitted with myo-
cardial infarction from 1994-1996 were studied. Patients admitted during the last 2 weeks
of December and the first week of January were compared with patients admitted all
other weeks. A model adjusting for patient, physician, hospital, and geographic charac-
teristics was used to determine a relationship between week of admission and the use of
proven therapies.
Results: Patients admitted during the holidays were less likely to receive aspirin, beta
blockers or reperfusion therapy, specifically primary coronary intervention (PCI) (Table 1).
Mortality in patients admitted during the holidays was also significantly higher at 30 days
and 1 year. After adjustment, patients admitted during the holidays remained less likely to
receive PCI (RR 0.9, p <0.01).
Conclusion: Patients admitted during holiday weeks are less likely to receive evidence-
based therapies, specifically primary coronary intervention.
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1096-67 Balloon Mitral Valvuloplasty Performed in Mobile 
Catheterization Laboratory as Part of Community 
Outreach Program at Primary Care Hospitals
Praveen Chandra, Ravi Kasliwal, S. N. Misra, B. Rawat, R. B. Panwar, Ajay Kanojia, 
Naresh Trehan, Ashok Seth, Escorts Heart Institute and Research Centre, New Delhi, 
India, Norvic, Nepal
Several patients of pure severe mitral stenosis suffer due to lack of definitive treatment
options like balloon mitral valvuloplasty (BMV) in developing countries, due to prevailing
socioeconomic conditions. We present a new strategy of taking tertiary level care to peo-
ple’s doorsteps by performing BMV in Mobile Cardiac Catheterization Laboratory near a
peripheral primary care hospital as part of a Community Outreach Program. Method:
This multicentric study performed at 6 centres in India and Nepal was divided into 2
phases. Phase I included 150 patients and all procedures were done with a surgical
standby. After the success of Phase I, 210 patients were treated in phase II, without sur-
gical standby. Patients were assessed for suitability for BMV by transthoracic echocardio-
gram (TTE) & transesophageal echocardiogram (TEE) in phase I and only TTE in phase
II. Exclusion criteria were moderate to severe mitral regurgitation (MR), presence of left
atrial or appendage clots and a Wilkins’ echocardiographic score of > 8. Procedure was
done using Inoue Balloon technique with TTE guidance. Results are summarized in the
table 1. Age range was 8-80 yrs and 53% were females . Conclusion: BMV is feasible
and safe even if done in a mobile catheterization laboratory in a primary care hospital
setting and can be undertaken without any surgical standby. These results are of
immense significance especially in developing countries where lack of facilities preclude
treatment of many deserving patients of severe mitral stenosis.
% with 4 drugs % with 3 drugs
2000 5.9 29.3
2001 10.9 34.1
2002 15.0 37.7
2003 11.4 42.4
Females/Males 9.0/10.8 31.9/35.0
Caucasian 9.6 34.2
African-American 18.6 31.8
Hispanic 15.1 32.0
Other 17.3 38.9
On Pump/Off Pump 10.2/10.6 32.7/36.3
Table 1: Use of Evidence-Based Therapies and Outcomes in Patients with Acute 
Myocardial Infarction
Holiday
Weeks
Rest of Year p 
Aspirin Use (during admission) 77.2% 78.2% 0.02
Aspirin Use (at discharge) 69.0% 69.5% 0.4
Beta Blocker Use (during admission) 43.3% 44.8% 0.002
Beta Blocker Use (at discharge) 28.7% 30.6% <0.0001
Reperfusion Therapy 16.3% 17.4% 0.004
Primary Coronary Intervention 12.5% 15.3% <0.0001
30-Day Mortality 22.5% 20.5% <0.0001
1-Year Mortality 37.2% 34.9% <0.0001
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1096-68 Why Is Echo Sometimes Inaccurate When Assessing 
Pediatric Heart Disease?
William L. Border, George H. Swingler, Thomas R. Kimball, Cincinnati Children's Hospital 
Medical Center, Cincinnati, OH
Background: A number of factors contribute to the performance and interpretation of
echocardiographic studies. Our purpose was to explore the determinants of diagnostic
error in children undergoing transthoracic echocardiography.
Methods: Periprocedural findings from consecutive patients undergoing surgery and/or
cardiac catheterization from 1998 to 2003, at a single institution, were compared with
transthoracic echo results. Factors pertaining to the patient, the performance of the study,
and the characteristics of the reader were recorded. These independent factors were
analyzed with multiple logistic regression to explain the diagnostic error rate.
Results: Information was recorded on 2,341 patients. A diagnostic error occurred in 16%
of the cases. The multiple logistic regression model explaining diagnostic error rate is
described below: 
The odds of diagnostic error were significantly increased if patient imaging was judged to
be problematic, and also if images were recorded digitally. An experienced echo reader
significantly decreased the odds of diagnostic error. The other two independent variables
did not achieve statistical significance in the model.
Conclusion: This study identifies factors that affect diagnostic error rate when perform-
ing transthoracic echocardiography in children with heart disease. This should help pedi-
atric cardiac centers target specific areas to ensure improved diagnostic performance.
1096-69 Case Method Learning Is a Cost Effective 
Implementation Method of Evidence Based Secondary 
Prevention in Primary Care
Anna Kiessling, Niklas Zethraeus, Peter Henriksson, Karolinska Institute, Stockholm, 
Sweden, Stockholm School of Economics, Stockholm, Sweden
Ojectives To study cost effectiveness of Case Method learning (CM) –on lipid lowering in
secondary prevention of coronary artery disease (CAD) in primary care.
Method A prospective randomized controlled trial in Södertälje, Stockholm County, Swe-
den. 255 consecutive patients with CAD were included. Guidelines were mailed to all
physicians (n=54) and presented at a common lecture. Physicians working at the primary
health care centers randomized to the intervention group, participated in recurrent CM
learning dialogues at their working site during a two-year period. A locally well-known
cardiologist served as a facilitator. Assessment of low-density lipoprotein (LDL) choles-
terol in a sample of their patients was performed at baseline and after two years. Analysis
according to intention-to-treat – intervention and control groups (n=88) – was based on
group affiliation at baseline. Cost of intervention included cost of the attendance of the
participants preparation, travel time and seminar time cost of the facilitator; and the
increased cost of lipid lowering drugs in the intervention and specialist groups during the
study period. Cost are as of 2002 with an exchange rate 1 US $ = 9.5 SEK (Swedish
Crowns).
Results Patients in the intervention group had their LDL cholesterol reduced by 0.5 (CI
0.1-0.9) mmol/l as compared to controls (9.3% reduction; p<0.05). No change occurred
in the control group. LDL cholesterol in the specialist group decreased by 0.6 (CI 0.4- 0.8)
mmol/l (12.6% reduction). Cost of intervention was 48.5 US $ per patient in the interven-
tion group and 80.9 US $ per patient in the specialist group. The cost per mmol decrease
of LDL cholesterol extrapolated to the duration of the 5.4 years in the 4S study is well
within the cost effectiveness of that study.
Conclusions CM learning resulted in cost effective LDL cholesterol lowering in the CAD
patients treated in primary care well within the effect and costs of a specialist clinic.
1096-70 Severe Concomitant Conditions, Physician Volumes 
and Outcomes in Acute Myocardial Infarction
Judith H. Lichtman, Zhenqiu Lin, Amir T. Fathi, Martha Radford, Jerry Wu, Caroline 
Loesser, Harlan M. Krumholz, Yale School of Medicine, New Haven, CT
Background. Studies looking at the relationship between physician (MD) volume and
mortality for AMI patients have not adjusted extensively for concomitant conditions. We
hypothesize that a substantial proportion of AMI patients present with severe concomi-
tant conditions, and are disproportionately cared for by MDs who treat a low volume of
AMI. These severe conditions, that merit admission in their own right, might explain
higher mortality rates for low volume MDs.
Methods. We examined in-hospital mortality among AMI patients enrolled in NRMI2 or
NRMI3 who were discharged from Yale-New Haven Hospital from January 1997 to June
2000. Average annual Medicare volume was used to create low (<3 AMI patients; below
median), mid (3-10), and high volume (11+) categories for attending MDs. NRMI vari-
ables were used to adjust for demographic, cardiac history, clinical presentation, and ini-
tial treatment factors. Criteria were created to identify life-threatening (LT) cardiac and
non-cardiac conditions at presentation using discharge summaries and NRMI data. Gen-
eralized estimating equation methods were used to sequentially adjust for these factors,
using high volume as the referent group.
Results. The study included 1,295 AMI patients (mean of 68 years, 41% women, 83%
white). Cardiologists treated 19%, 34%, and 98% of AMIs respectively from low to high
volume. Presentation of LT cardiac events was similar by volume (12%). Overall, 9% pre-
sented with LT non-cardiac events, but varied from low to high volume (19%, 14%, 5%).
Unadjusted mortality decreased by MD volume (13.4%, 9.5%, and 6.5%), but was con-
sistently lower for cardiologists within each volume category. Overall, patients seen by
low and mid volume MDs had similar comorbid profiles. The unadjusted mortality risk for
the mid volume group was eliminated after sequential risk adjustment, whereas the risk
for low volume MDs was attenuated but not eliminated (OR 1.7, 95% 0.9-3.0).
Conclusion. Almost 1 in 10 AMI patients present with a severe concomitant condition.
While patients who present with these serious conditions are more commonly seen by
low volume MDs, risk adjustment for these factors does not explain the excess mortality
for low volume providers.
1096-71 A National Survey of Health Care Practitioners’ 
Knowledge of the QT Interval
Sana M. Al-Khatib, Nancy M. Allen LaPointe, Judith M. Kramer, Anita Y. Chen, Bradley G. 
Hammill, Liz DeLong, Robert M. Califf, Duke Clinical Research Institute, Durham, NC
Background: Several medications are associated with QT interval prolongation that can
predispose patients to a potentially fatal arrhythmia known as torsades de pointes. The
safe use of these medications is dependent on health care practitioners’ knowledge of
the QT interval. We conducted this survey to assess health care practitioners’ ability to
correctly measure the QT interval and to identify factors and medications that may
increase the risk of QT interval prolongation and torsades de pointes.
Methods: This cross-sectional national survey was administered between April 2002 and
March 2003 to health care practitioners attending Grand Rounds Conferences at six of
the top academic institutions in the United States in internal medicine and psychiatry and
at six community hospitals in the same geographical areas as the academic institutions.
Twenty questions on the QT interval were asked.
Results: Of approximately 826 attendees, 517 (63%) completed the survey. Of about
608 attendees of internal medicine conferences, 371 (61%) responded, and of about 208
attendees of psychiatry conferences, 146 (67%) responded. The median number of cor-
rect answers for the whole group was 10 (interquartile range 7-13). The median number
of correct answers for internists was 12 (interquartile range 9-13), for psychiatrists was
10 (interquartile range 7-13) and for other specialists was 10 (interquartile range 5-13).
Respondents who graduated between 1990 and 1999 and academicians performed sig-
nificantly better overall than other respondents. Of the 517 respondents, 224 (43%) mea-
sured the QT interval correctly. Physicians in training, academicians and non-psychiatry
specialists were more likely to measure the QT interval correctly.
Conclusion: The majority of health care practitioners cannot correctly measure the QT
interval and cannot correctly identify factors and medications that can prolong the QT
interval. Our findings suggest that educational programs on the QT interval are urgently
needed.
1096-72 Noise Exposure and the Risk of Myocardial Infarction
Stefan N. Willich, Thomas Keil, Wolfgang Babisch, Marianne Schust, Heide Stark, 
Martina Stallmann, Karl Wegscheider, Charité, University Medical Center, Berlin, 
Germany
Background: Chronic noise exposure has been shown to be associated with increased
catecholamine levels and adverse effects on blood pressure and plasma lipids, and may
thus contribute to the progression of coronary artery disease.
Methods: To determine the potential risk of noise for the incidence of myocardial infarc-
tion (MI), consecutive patients admitted to all 32 major hospitals in Berlin with confirmed
diagnosis of acute MI were enrolled from 1998 to 2001 in the NaRoMI Study (Noise and
Risk of Myocardial Infarction). Controls were matched according to gender, age, and hos-
pital. In standardized computerized interviews conducted during the hospital stay infor-
mation was obtained on the sources and degree (on a continuous 5 point scale) of noise
annoyance. The 10 years work noise exposure levels were determined according to ISO
9921/1. In multiple logistic regression models, the odds ratios (OR) of noise variables
were adjusted for cardiovascular risk factors and sociodemographic variables.
Results: A total of 4,115 patients (3,054 men, 56+/-9 years, 1,061 women, 58+/-9 years)
were included in the study. Annoyance by environmental noise (including street, air and
railway traffic, industrial and construction noise) was associated with increased risk of MI
in women (OR crude 1.40; 95% confidence interval 1.01-1.94 per unit, OR adjusted 1.30;
table 1
Phase I; (n=150) Phase II (without 
surgical 
standby) 
(n=210)
Procedural success 100% 100%
mitral valve orifice area-Pre-BMV cm2 0.81+/- 0.21 0.85 +/- 0.15
mitral valve orifice area-Post-BMVcm2 1.91 +/- 0.38 2.0 +/- 0.40
mitral mean pressure gradient Pre-BMV mmHg 12.5 +/- 4.6 13.1 +/- 3.9
mitral mean pressure gradient Post-BMV mmHg 2.5 +/- 1.9 2.2 +/- 1.6
post BMV significant MR 3 (2%) 5 (2.3%)
complications requiring urgent surgery 0 0
Odds ratio for 
diagnostic 
error
Standar
d Error
P-value 95 % CI
Patient imaging judged to be 
problematic
3.04 0.46 <0.001 0.28-0.47
Digital vs tape acquisition 1.38 0.22 0.045 1.01-1.90
Institution performing echo does 
>4000 studies/year
0.76 0.27 0.43 0.38-1.50
Echo requisition form present 0.63 0.21 0.17 0.33-1.22
Dedicated echo reader with > 3 years 
experience at tertiary cardiac center
0.36 0.05 <0.001 0.28-0.47
